Works by Okimoto, Nobukazu

Results: 46
    1
    2

    Early‐onset dementia and risk of hip fracture and major osteoporotic fractures.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 5, p. 3388, doi. 10.1002/alz.13815
    By:
    • Matsumoto, Shoya;
    • Hosoi, Tatsuya;
    • Yakabe, Mitsutaka;
    • Fujimori, Kenji;
    • Tamaki, Junko;
    • Nakatoh, Shinichi;
    • Ishii, Shigeyuki;
    • Okimoto, Nobukazu;
    • Akishita, Masahiro;
    • Iki, Masayuki;
    • Ogawa, Sumito
    Publication type:
    Article
    3

    Successful Reboot of High-Performance Sporting Activities by Japanese National Women's Handball Team in Tokyo, 2020 during the COVID-19 Pandemic: An Initiative Using the Japan Sports–Cyber Physical System (JS–CPS) of the Sports Research Innovation Project (SRIP)

    Published in:
    International Journal of Environmental Research & Public Health, 2021, v. 18, n. 18, p. 9865, doi. 10.3390/ijerph18189865
    By:
    • Ogasawara, Issei;
    • Hamaguchi, Shigeto;
    • Hasegawa, Ryosuke;
    • Akeda, Yukihiro;
    • Ota, Naoki;
    • Revankar, Gajanan S.;
    • Konda, Shoji;
    • Taguchi, Takashi;
    • Takanouchi, Toshiya;
    • Imoto, Kojiro;
    • Okimoto, Nobukazu;
    • Sakuma, Katsuhiko;
    • Uchiyama, Akira;
    • Yamasaki, Keita;
    • Higashino, Teruo;
    • Tomono, Kazunori;
    • Nakata, Ken
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Treatment with once‐weekly alendronate oral jelly compared with once‐weekly alendronate oral tablet for Japanese patients with primary osteoporosis: An open‐label, prospective, observational study.

    Published in:
    Health Science Reports, 2019, v. 2, n. 1, p. N.PAG, doi. 10.1002/hsr2.107
    By:
    • Okimoto, Nobukazu;
    • Uemura, Yukari;
    • Yoshioka, Toru;
    • Arita, Shinobu;
    • Tsurukami, Hiroshi;
    • Otomo, Hajime;
    • Nishida, Satoshi;
    • Ogawa, Takayuki;
    • Hirao, Ken;
    • Ikeda, Satoshi;
    • Matsumoto, Hidehiro;
    • Toten, Yoriko;
    • Katae, Yuji;
    • Okazaki, Yuichi;
    • Nakagawa, Tsuyoshi;
    • Sakai, Akinori
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Effects of differences in dose and frequency of teriparatide on bone structure in Proximal Femur. – Analysis by DXA-based 3D-modeling (3D-SHAPER Software) –TRIPLE-BONE study (The effects of TeRIParatide preparation on bone mineraL density increase and BONE structure)

    Published in:
    Archives of Osteoporosis, 2024, v. 19, n. 1, p. 1, doi. 10.1007/s11657-024-01415-1
    By:
    • Takada, Junichi;
    • Okimoto, Nobukazu;
    • Tsukamoto, Manabu;
    • Akatsuka, Tomohiro;
    • Takebayashi, Tsuneo;
    • Iba, Kousuke;
    • Ikeda, Satoshi
    Publication type:
    Article
    23
    24
    25

    The impact of chronic obstructive pulmonary disease on bone strength.

    Published in:
    Journal of Bone & Mineral Metabolism, 2024, v. 42, n. 4, p. 421, doi. 10.1007/s00774-024-01496-5
    By:
    • Tsukamoto, Manabu;
    • Nabeshima, Takayuki;
    • Wang, Ke-Yong;
    • Mano, Yosuke;
    • Arakawa, Daisuke;
    • Okada, Yasuaki;
    • Yamanaka, Yoshiaki;
    • Okimoto, Nobukazu;
    • Sakai, Akinori
    Publication type:
    Article
    26
    27
    28
    29
    30
    31

    Efficacy of non-steroidal anti-inflammatory drugs on zoledronic acid-induced acute-phase reactions: randomized, open-label, Japanese OZ study.

    Published in:
    2020
    By:
    • Okimoto, Nobukazu;
    • Sakai, Akinori;
    • Yoshioka, Toru;
    • Kobayashi, Tomohiro;
    • Asano, Kei;
    • Akahoshi, Shojiro;
    • Ishikura, Toru;
    • Fukuhara, Shito;
    • Fuse, Yoshifumi;
    • Mizuno, Toshiyuki;
    • Katae, Yuji;
    • Matsumoto, Hidehiro;
    • Ogawa, Takayuki;
    • Nishida, Shigeki;
    • Ikeda, Satoshi;
    • Menuki, Kunitaka;
    • Saito, Jun;
    • Okazaki, Yuichi;
    • Mizuno, Naoyuki;
    • Fujiwara, Saeko
    Publication type:
    journal article
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan

    Published in:
    Osteoporosis International, 2024, v. 35, n. 5, p. 805, doi. 10.1007/s00198-024-07023-6
    By:
    • Iki, Masayuki;
    • Fujimori, Kenji;
    • Nakatoh, Shinichi;
    • Tamaki, Junko;
    • Ishii, Shigeyuki;
    • Okimoto, Nobukazu;
    • Imano, Hironori;
    • Ogawa, Sumito
    Publication type:
    Article
    41
    42
    43
    44
    45
    46